A PBM Oligopoly: Three Companies Control 80% Of US Prescriptions

  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 42 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 37%
  • Publisher: 59%

Ftc Nouvelles

Pbms,Pharmaceuticals,Pharmacy

I’m an internationally recognized consultant and author with over 25 years of experience in the field of strategy development and execution, business model design, and market analysis.

on Pharmacy Benefit Managers has authoritatively documented the multiple ways in which the three largest PBMs have contributed to the rising cost of drugs. This investigation has shown a spotlight on a list of questionable practices that have long been the subject of complaints from consumers, independent pharmacies, pharmaceutical manufacturers, employers and other stakeholders.

However, PBMs make their money through more than rebates—and to curb these perverse incentives, the FTC needs to explore other practices too.that PBM compensation from these fees doubled in just four years, skyrocketing from $3.8 billion in 2018 to $7.6 billion in 2022. These fees represent a strategy by PBMs to maintain their profit margins as traditional revenue streams have come under scrutiny.

The vertical integration of PBMs with pharmacy chains has created a closed loop of self-dealing. From selective contracting to patient steering and narrow networks, these behemoths are systematically funneling patients into their own ecosystems. PBMs reserve in-network status for pharmacy chains owned by their parent corporations, an obvious form of self-dealing that limits patient options and stifles competition.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 318. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Stocks are little changed Tuesday as traders await key tech earnings: Live updatesThe three major indexes were slightly lower on Tuesday ahead of earnings reports from major companies.
La source: CNBC - 🏆 12. / 72 Lire la suite »